Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022

Report Overview

Table of Contents

1699

Select License Type

£1,699.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£4,999.00	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£6,999.00	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,699.00	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Healthcare and Medical
Report Type	Market Research
Country	Global
Published	15 February 2012
Number of Pages	140
Report Delivery	Email
Delivery Lead Time	1-3 hours, 24 hour max
Publisher	Visiongain
File Format	PDF

Leading Pre-Filled Syringe Manufacturers 2012 - In 2012, five companies accounted for over 90% of sales of pre-filled syringes to the pharmaceutical industry. BD, Gerresheimer and Schott are currently the biggest players in the market, followed by MGlas and Nuova Ompi. These companies each offer a broad range of pre-filled syringe products, including complete syringe systems and syringe components. Some, such as BD, also offer autoinjectors and pen injectors for use with pre-filled syringes and cartridges. These five leading companies are discussed in more detail in chapters 3-5 and in chapter 9. As no specific pre-filled syringe sales data is available for any of these companies, they are reviewed alphabetically, rather than being ranked in terms of market share. However, it is widely accepted that BD is by far the biggest player in this market, visiongain notes. Some estimates suggest that this company's market share is between 50% and 80% of the pre-filled syringe market.

Chapters 6 and 7 provide profiles of two of the leading pre-filled syringe component manufacturers. West and Datwyler provide a number of components for pre-filled syringes, including needle shields, tip caps and coated plungers. Additionally, West manufactures plastic pre-filled syringes and autoinjectors, visiongain notes. Stelmi, another component manufacturer, is profiled in chapter 9. Similarly to the pre-filled syringe market, the pen injector and autoinjector market is dominated by relatively few companies, including BD. Ypsomed, profiled in chapter 8, manufactures a number of pen injectors for insulin administration, as well as for other therapy areas. The company also manufactures autoinjectors. Other leading pen injector and autoinjector manufacturers include Owen Mumford and SHL Group.

Given the dominance of the leading companies at the beginning of 2012, the make-up of the leading companies market is not expected to change significantly during the forecast period. There are a number of smaller companies developing innovative products, particularly in the safety syringe sector, which will result in rising revenues from 2012 to 2022. However, the market-leading companies are also investing in this area and so will expect to compete strongly with the smaller players.

Report Scope

- Assess leading syringe producers, discovering their activities and outlooks
- Discover world market, submarket and product revenue forecasts to 2022
- Receive analyses of companies, seeing revenue forecasts to 2022
- View a comparative analysis of pre-filled syringe manufacturers
- See opinions from our survey, receiving views from companies
- Find existing revenues and operational data for leading companies
- Review technological developments, assessing trends and prospects
- Analyse prospects for applications of injection devices from 2012
- Investigate competition and opportunities influencing revenues
- Find out what will stimulate and restrain the industry and market.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£1,699.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£4,999.00	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£6,999.00	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,699.00	Add to Wishlist
Change Currency	GBP EURO USD

1. Executive Summary

1.1 Overview of Findings
1.2 Chapter Breakdown
1.3 Research and Analysis Methods
1.4 Scope of this Report
1.5 Terminology Used in this Report

2. An Introduction to Pre-Filled Syringe Manufacturing

2.1 Components of Pre-Filled Syringes
2.1.1 Pen Injectors and Autoinjectors

2.2 Demand for Pre-Filled Syringes
2.2.1 Advantages of Pre-Filled Syringes

2.3 The Future of Pre-Filled Syringes
2.3.1 The Pre-Filled Syringe Market 2010-2011
2.3.1.1 Regional Analysis of the Pre-Filled Syringe Market 2010-2011
2.3.2 The Pre-Filled Syringe Market 2012-2022
2.3.2.1 Pre-Filled Syringes vs. Other Drug Delivery Technologies: Market Forecast 2012-2022
2.3.3 Pen Injector and Autoinjector Submarket: Revenue Forecast 2012-2022

2.4 Leading Pre-Filled Syringe Manufacturers 2012

3. Becton, Dickinson & Co (BD)

3.1 Company Overview

3.2 Pre-Filled Syringe Products
3.2.1 BD Hypak Syringe Systems
3.2.2 BD Sterifill Syringe Systems
3.2.3 BD Soluvia
3.2.4 BD Uniject
3.2.5 BD Physioject
3.2.6 BD Pen Systems
3.2.7 BD Safety Systems

3.3 Recent Financial Performance

3.4 Strategy Analysis and Future Outlook
3.4.1 A Dominant Market Presence
3.4.2 Continued Expansion
3.4.3 Future Demand for BD's Products
3.4.4 BD Medical - Pharmaceutical Systems: Revenue Forecast 2012-2022
3.4.5 PegIntron: Revenue Forecast 2012-2022
3.4.6 Concluding Remarks

4. Gerresheimer

4.1 Company Overview

4.2 Pre-Filled Syringe Products
4.2.1 Ready-To-Fill (RTF) Syringes
4.2.2 ClearJect
4.2.3 Insulin Pens

4.3 Recent Financial Performance
4.3.1 RTF Manufacturing Expansion
4.3.2 Increased Interest in Plastics
4.3.3 Emerging Market Focus

4.4 Strategy Analysis and Future Outlook
4.4.1 Growing Demand for Plastics
4.4.2 Acquisitions for Expansion
4.4.2.1 Gerresheimer in Emerging Markets
4.4.3 Lantus: Revenue Forecast 2012-2022
4.4.4 Concluding Remarks

5. Schott

5.1 Company Overview

5.2 Pre-Filled Syringe Products
5.2.1 Forma 3s Glass Syringes
5.2.2 TopPac Polymer Syringes
5.2.3 InJentle Syringes

5.3 Recent Financial Performance
5.3.1 US Expansion
5.3.2 Asian Expansion

5.4 Strategy Analysis and Future Outlook
5.4.1 Diverse Syringe Portfolio
5.4.2 New Market Focus
5.4.3 Concluding Remarks

5.5 Company Insight

6. Datwyler

6.1 Company Overview

6.2 Pre-Filled Syringe Products
6.2.1 Omniflex Coating
6.2.2 Datwyler FirstLine

6.3 Recent Financial Performance
6.3.1 Global Expansion
6.3.2 Continued Product Development

6.4 Strategy Analysis and Future Outlook
6.4.1 Reinforcing its Presence in Asia
6.4.2 Meeting the Demands of the Pharmaceutical Industry
6.4.3 Datwyler Pharma Packaging: Revenue Forecast 2012-2022
6.4.4 Concluding Remarks

6.5 Company Insight
6.5.1 Datwyler's Recent Performance
6.5.2 Future Strategies
6.5.3 Outlook for the Pre-Filled Syringe Market

7. West Pharmaceutical Services

7.1 Company Overview

7.2 Pre-Filled Syringe Components and Products
7.2.1 Daikyo Crystal Zenith (CZ)
7.2.2 MixJect
7.2.3 ConfiDose Autoinjector
7.2.4 Éris Safety Syringe

7.3 Recent Financial Performance
7.3.1 Expanded Product Portfolio

7.4 Strategy Analysis and Future Outlook
7.4.1 Products Beyond Syringe Components
7.4.2 Investing to Expand
7.4.3 Concluding Remarks

7.5 Company Insight
7.5.1 West's Recent Performance
7.5.2 Future Strategies
7.5.3 Outlook for the Pre-Filled Syringe Market

8. Ypsomed

8.1 Company Overview

8.2 Ypsomed's Product Portfolio: Pen Injectors and Autoinjectors
8.2.1 YpsoPen
8.2.2 ServoPen
8.2.3 UnoPen
8.2.4 LyoTwist
8.2.5 Ypsomed Autoinjectors

8.3 Recent Financial Performance
8.3.1 A Move to Automation
8.3.2 The Importance of Diabetes

8.4 Strategy Analysis and Future Outlook
8.4.1 A Large and Growing Product Range
8.4.1.1 Focus Away From Injection Systems
8.4.2 A Partner for Big Pharma
8.4.2.1 Genotropin: Revenue Forecast 2012-2022
8.4.3 Delivery Devices: Revenue Forecast 2012-2022
8.4.4 Concluding Remarks

8.5 Company Insight
8.5.1 The Changing Demands of Customers
8.5.1.1 Recent Demand
8.5.1.2 Future Demand
8.5.2 Trends in Autoinjectors

9. Other Leading Pre-Filled Syringe Companies

9.1 MGlas
9.1.1 Company Overview
9.1.2 Pre-Filled Syringe Products
9.1.3 Merger Speculation
9.1.4 Company Analysis

9.2 Nuova Ompi
9.2.1 Company Overview
9.2.2 Pre-Filled Syringe Products
9.2.2.1 EZ-Fill
9.2.3 Company Analysis
9.2.4 Company Insight
9.2.4.1 Nuova Ompi's Recent Performance
9.2.4.2 Future Strategies
9.2.4.3 Outlook for the Pre-Filled Syringe Market

9.3 Stelmi
9.3.1 Company Overview
9.3.2 Pre-Filled Syringe Components
9.3.2.1 Rigid Needle Shields
9.3.3 Recent Financial Performance
9.3.4 Company Analysis

9.4 Owen Mumford
9.4.1 Company Overview
9.4.2 Pen Injectors and Autoinjectors
9.4.2.1 Autoject
9.4.2.2 Autopen
9.4.2.3 SimpleJect
9.4.3 Recent Financial Performance
9.4.3.1 Copaxone: Revenue Forecast 2012-2022
9.4.4 Company Analysis
9.4.4.1 Humira: Revenue Forecast 2012-2022

9.5 SHL Group
9.5.1 Company Overview
9.5.2 Pen Injectors and Autoinjectors
9.5.2.1 Molly Autoinjector
9.5.2.2 DAI Autoinjectors
9.5.3 Recent Performance
9.5.3.1 Expanding Manufacturing Facilities
9.5.4 Company Analysis
9.5.4.1 Aranesp: Revenue Forecast 2012-2022

10. Market Leaders: Product and Strategy Comparison of Companies

10.1 Competitor Analysis
10.1.1 Pre-Filled Syringes
10.1.2 Pen Injectors and Autoinjectors

10.2 Common Development Strategies
10.2.1 Emerging-Market Expansion
10.2.2 Biologics and Biosimilars
10.2.3 Safety Innovations
10.2.3.1 Competitors in Safety Products
10.2.3.2 Safety Syringes
10.2.4 Investment in Other Drug Delivery Technologies

10.3 Up and Coming Pre-Filled Syringe Manufacturers
10.3.1 Unilife
10.3.2 Revolutions Medical

10.4 Concluding Remarks
10.5 Company Survey
10.6 Company Details

List of Tables

Table 1.1 Currency Exchange Rates
Table 2.1 Pre-Filled Syringes Market by Sector, 2010-2011
Table 2.2 Pre-Filled Syringes Market: Overall Market and Submarket Revenue Forecasts, 2010-2022
Table 2.3 Drug Delivery Technologies Market by Sector, 2010
Table 2.4 Drug Delivery Technologies: Overall Market and Submarket Revenue Forecasts, 2010-2022
Table 2.5 Leading Pre-Filled Syringe and Related Technology Manufacturers, 2012
Table 3.1 BD: Company Revenue, 2006-2011
Table 3.2 BD Medical: Revenue by Segment, 2009-2011
Table 3.3 BD Medical - Pharmaceutical Systems: Revenue Forecast, 2010-2022
Table 3.4 PegIntron: Revenue Forecast, 2010-2022
Table 4.1 Gerresheimer: Employees by Division, 2010
Table 4.2 Gerresheimer: Revenue by Division, 2009 & 2010
Table 4.3 Lantus: Revenue Forecast, 2010-2022
Table 5.1 Schott: Revenue 2008-2010
Table 5.2 Schott Survey Results: Production Capacity and Customer Demands, 2012
Table 6.1 Datwyler Pharma Packaging: Employees by Country, 2011
Table 6.2 Datwyler: Revenue by Division, 2007-2010
Table 6.3 Datwyler Pharma Packaging: Revenue and EBIT, Half-Year 2010 & 2011
Table 6.4 Datwyler Pharma Packaging: Revenue Forecast, 2010-2022
Table 7.1 West Pharmaceutical Services: Revenue by Segment, 2008-2010
Table 7.2 West Delivery Systems: Revenue by Segment, 2008-2010
Table 8.1 Ypsomed: Group Companies, 2011
Table 8.2 Ypsomed: Major Pharmaceutical Partners, 2011
Table 8.3 Ypsomed: Revenue by Segment, 2009-2011
Table 8.4 Ypsomed: Half-Year Revenue by Segment, 2011 & 2012
Table 8.5 Genotropin: Revenue Forecast, 2010-2022
Table 8.6 Ypsomed Delivery Devices: Revenue Forecast, 2010-2022
Table 9.1 Stelmi: Revenue, 1999-2007
Table 9.2 Owen Mumford: Revenue, 2009 & 2010
Table 9.3 Copaxone: Revenue Forecast, 2010-2022
Table 9.4 Humira: Revenue Forecast, 2010-2022
Table 9.5 SHL Group: Pen Injectors and Autoinjectors, 2012
Table 9.6 Aranesp: Revenue Forecast, 2010-2022
Table 10.1 Glass Pre-Filled Syringes: Leading Product Comparisons, 2012
Table 10.2 Plastic Pre-Filled Syringes: Product Comparisons, 2012
Table 10.3 Pen Injectors: Product Comparisons, 2012
Table 10.4 Autoinjectors: Product Comparisons, 2012
Table 10.5 Leading Manufacturers: Emerging-Market Strategies
Table 10.6 Biological Drugs: World Market Forecast, 2010, 2016 & 2022
Table 10.7 Selected Pre-Filled Syringe Products Available for Biologics, 2012
Table 10.8 Insulin: World Market Forecast, 2010-2022
Table 10.9 Vaccine Inhalers Currently Under Development, 2012
Table 10.10 Other Drug Delivery Devices Offered by Leading Players, 2012
Table 10.11 Unilife: Revenue by Segment, 2009-2011
Table 10.12 BD: Key Facts, 2012
Table 10.13 Gerresheimer: Key Facts, 2012
Table 10.14 Schott: Key Facts, 2012
Table 10.15 MGlas: Key Facts, 2012
Table 10.16 Nuova Ompi: Key Facts, 2012
Table 10.17 Datwyler: Key Facts, 2012
Table 10.18 West: Key Facts, 2012
Table 10.19 Stelmi: Key Facts, 2012
Table 10.20 Ypsomed Key Facts, 2012
Table 10.21 Owen Mumford Key Facts, 2012
Table 10.22 SHL Group Key Facts, 2012

List of Figures

Figure 2.1 Pre-Filled Syringes Market by Sector, 2010-2011
Figure 2.2 Pre-Filled Syringes Market: Overall Revenue Forecast, 2010-2022
Figure 2.3 Drug Delivery Technologies Market by Sector, 2010
Figure 2.4 Drug Delivery Technologies: Market Forecast, 2010-2022
Figure 2.5 Drug Delivery Technologies: Submarket Shares, 2016
Figure 2.6 Drug Delivery Technologies: Submarket Shares, 2022
Figure 2.7 Pen Injectors and Autoinjectors Submarket: Revenue Forecast, 2010-2022
Figure 2.8 Other Pre-Filled Syringe Products Submarket: Revenue Forecast, 2010-2022
Figure 3.1 BD: Company Revenue, 2006-2011
Figure 3.2 BD Medical: Revenue by Segment, 2009-2011
Figure 3.3 BD Medical - Pharmaceutical Systems: Opportunities and Threats, 2012-2022
Figure 3.4 BD Medical - Pharmaceutical Systems: Revenue Forecast, 2010-2022
Figure 3.5 PegIntron: Revenue Forecast, 2010-2022
Figure 4.1 Gerresheimer: Employees by Division, 2010
Figure 4.2 Gerresheimer: Revenue by Division, 2009-2010
Figure 4.3 Gerresheimer: Opportunities and Threats, 2012-2022
Figure 4.4 Lantus: Revenue Forecast, 2010-2022
Figure 5.1 Schott: Revenue 2008-2010
Figure 5.2 Schott: Opportunities and Threats, 2012-2022
Figure 5.3 Schott Survey Results: Trends from the Pharmaceutical Industry
Figure 5.4 Schott Survey Results: Demands from the Market and Future Product Requirements
Figure 6.1 Datwyler Pharma Packaging: Employees by Country, 2011
Figure 6.2 Datwyler Pharma Packaging: Revenue, 2007-2010
Figure 6.3 Datwyler Pharma Packaging: Revenue and EBIT, Half-Year 2010 & 2011
Figure 6.4 Datwyler Pharma Packaging: Opportunities and Threats, 2012-2022
Figure 6.5 Datwyler Pharma Packaging: Revenue Forecast, 2010-2022
Figure 7.1 West Pharmaceutical Services: Revenue by Segment, 2008-2010
Figure 7.2 West Delivery Systems: Revenue by Segment, 2008-2010
Figure 7.3 West Pharmaceutical Services: Opportunities and Threats, 2012-2022
Figure 8.1 Ypsomed: Revenue by Segment, 2009-2011
Figure 8.2 Ypsomed: Half-Year Revenue by Segment, 2011 & 2012
Figure 8.3 Ypsomed Delivery Devices: Opportunities and Threats, 2012-2022
Figure 8.4 Genotropin: Revenue Forecast, 2010-2022
Figure 8.5 Ypsomed Delivery Devices: Revenue Forecast, 2010-2022
Figure 9.1 Stelmi: Revenue, 2001, 2004 & 2007
Figure 9.2 Owen Mumford: Revenue, 2009 & 2010
Figure 9.3 Copaxone: Revenue Forecast, 2010-2022
Figure 9.4 Humira: Revenue Forecast, 2010-2022
Figure 9.5 Aranesp: Revenue Forecast, 2010-2022
Figure 10.1 Biological Drugs: World Market Forecast, 2010, 2016 & 2022
Figure 10.2 Insulin: World Market Forecast, 2010-2022
Figure 10.3 Unilife: Revenue by Segment, 2009-2011

Companies Listed

Abbott Laboratories
Alfamatic (part of the Stevanato Group)
American Stelmi
Amgen
Amylin Pharmaceuticals
Antares Pharma
B. Braun
Baxter BioPharma Solutions (part of Baxter International)
Baxter International
Bayer
Becton, Dickinson & Co (BD)
Biogen Idec
Boehringer Ingelheim
Cambridge Consultants
Carmel Pharma
Catalent
CeifiT
Daikyo Seiko
Datwyler Group
Diagenode
Disetronic Group (now part of Roche)
Dongbao
DS WorldMed
Eisai
Elan
Eli Lilly
European Medicines Agency (EMA)
Food and Drug Administration (FDA) [US]
Genentech (now part of Roche)
Generex
Gerresheimer
Gerresheimer Bünde (subsidiary of Gerresheimer)
GSK
Harvard University
Inhibitex
Insulet
J&J
La Model (now part of West)
Ligocyte Pharmaceuticals
Medical Glass (part of the Stevanato Group)
MedImmune
Medimop Medical Projects (now part of West)
MedPro Safety Products
Merck & Co.
Merck Serono (also Merck KGaA)
MG Sterile Products
MGlas
MGlas Scandinavia (formerly Pharmapack Packaging Systems)
Ministry of Health [Brazil]
Momenta
Mylan
Naigai Glass Industry Co
Natco
Nektar Therapeutics
Nippon Zeon Co
Novartis
Novo Nordisk
Nuova Ompi (part of the Stevanato Group)
Nycomed (now part of Takeda)
Ompi of America (part of the Stevanato Group)
Optrel (subsidiary of Spami)
Otsuka Pharmaceutical
Owen Mumford
PATH
Pertinax (now part of SHL Group)
Pfizer
Pharma-Pen (now part of West)
PharmaPraxis
Pharmasset
Pharmstandard
Plastef Investissements
Polfa Tarchomin
Revolutions Medical
Roche
Rumpler Technologies
Safety Syringes
Sandoz
Sanofi
Sanofi Pasteur (part of Sanofi)
Schering-Plough (now part of Merck & Co.)
Schott
SHL Group
Spami (part of the Stevanato Group)
Stelmi
Stelmi Asia
Stevanato Group
Taisei Kako Co
Teva Pharmaceutical Industries
tip-top
Tonghua Dongbao Pharmaceutical Co
Unilife
University of Colorado
US Agency for International Development (USAID)
Védat (now part of Gerresheimer)
Vertex Pharmaceuticals
Vetter Pharma
Watson Pharmaceuticals
West Company Mexico (subsidiary of West)
West Pharmaceutical Services
Ypsomed and its subsidiaries:
DiaExpert
feelfree
Ypsomed AB
Ypsomed BV
Ypsomed Distribution
Ypsomed GmbH
Ypsomed India Private Ltd
Ypsomed Ltd
Ypsomed SAS
Ypsotec
Ypsotec s.r.o.
Zhejiang Xinkang Pharmaceutical Glass Co

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022

Healthcare and Medical Company Profiles

Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022

Select License Type

Report Scope

Speak to an Advisor

Select License Type

Table of Contents

1. Executive Summary

2. An Introduction to Pre-Filled Syringe Manufacturing

3. Becton, Dickinson & Co (BD)

4. Gerresheimer

5. Schott

6. Datwyler

7. West Pharmaceutical Services

8. Ypsomed

9. Other Leading Pre-Filled Syringe Companies

10. Market Leaders: Product and Strategy Comparison of Companies

List of Tables

List of Figures

Companies Listed

Visitor Comments

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Competitor Tracking

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Republic of the Congo
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel